We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:6089P
GW Pharmaceuticals PLC
07 March 2008
07 March 2008
GW Pharmaceuticals plc
("GW" or "the Company")
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
The company has today been notified that on 4th March 2008 Dr Brian Whittle, a
Director of the Company, gifted for nil consideration a total of 100,000
ordinary shares of 0.1p to a medical charity. The gift amounts to 0.08% of the
issued ordinary share capital.
Following this notification Dr Whittle retains a beneficial interest in
10,158,446 ordinary shares, amounting to 8.44% of the shares in issue.
Enquiries:
GW Pharmaceuticals plc 01980 557000
Adam George, Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSILFLLVSIDIIT
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
